Importance Immune-mediated inflammatory diseases (IMIDs) and COVID-19 are
independently associated with venous thromboembolisms (VTEs). Objective To determine if …

Importance Patients hospitalized with COVID-19 have higher rates of venous
thromboembolism (VTE), but the risk and predictors of VTE among individuals with less …

Purpose Few studies have examined how the absolute risk of thromboembolism with COVID-
19 has evolved over time across different countries. Researchers from the European …

Background Although the incidence of venous and arterial thrombosis after a COVID-19
diagnosis and hospitalization has been well described using data available from electronic …

Introduction Infection with SARS-CoV-2 is typically compared with influenza to contextualize
its health risks. SARS-CoV-2 has been linked with coagulation disturbances including …

Importance The risk of venous thromboembolism (VTE) in ambulatory COVID-19 is
controversial. In addition, the association of vaccination with COVID-19–related VTE and …

Ambulatory patients with coronavirus disease 2019 (COVID-19) have a low risk of
developing venous thromboembolism (VTE), whereas hospitalization is associated with a …

Venous thromboembolism (VTE) in patients with COVID-19 in intensive care units (ICU) is
frequent, but risk factors (RF) remain unidentified. In this meta-analysis (CRD42020188764) …

Background: COVID-19 increases the risk of venous thromboembolism (VTE) through a
complex interplay of mechanisms collectively referred to as immunothrombosis. Limited data …

Background The reported incidence of venous thromboembolism (VTE) in COVID-19
patients varies widely depending on patient populations sampled and has been …